An Indian appellate ruling has upended how pharmaceutical patent evidence gets collected across borders. If your cases touch ...

Your article "Why India's patent battles matter" shows initial disagreement mounting towards patented drugs, which is likely to continue for three or four more years. Notably, this disagreement is ...

The Indian Ministry of Commerce and Industry, which administers the Department for Promotion of Industry & Internal Trade, published changes to its 2003 Patent Rules in its Official Gazette on March ...

India’s rising global presence is often associated with its booming tech sector. But in many poor countries, India’s role is that of a low-cost pharmacy. The country has become a leading supplier of ...

An Indian court rejected Novartis's attempt to change Indian law so it would be easier to patent drugs, in a case that underscores the growing tension between public-health interests and intellectual ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Cancer patients in India have reason to be relieved at a high court ruling this week which dismissed a petition by Swiss pharmaceuticals multinational corporation (MNC) Novartis challenging an Indian ...

NEW DELHINEW DELHI — From Africa’s crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a ...

Speaking at the International Workshop on 6G Standardization at Vigyan Bhawan, the Minister outlined a strategic vision ...

MUMBAI (Reuters) - India's patent office has rejected an application from U.S.-based Gilead Sciences Inc for its hepatitis C drug Sovaldi, paving the way for local drugmakers to launch cheaper generic ...